Navigation Links
Two Sepsis Treatments Look Equally Effective
Date:2/23/2010

Study attempts to settle ongoing debate

TUESDAY, Feb. 23 (HealthDay News) -- Two treatment methods for severe sepsis achieve similar short-term survival rates, a new study shows.

Researchers at the Carolinas Medical Center in Charlotte, N.C., compared lactate clearance (using lactate levels measured in blood samples) with a treatment involving central venous oxygen saturation (ScvO2) measured using a catheter connected to a computerized system. The Surviving Sepsis Campaign guidelines recommend the use of ScvO2, but there is ongoing debate about which of the two methods is better.

The study looked at outcomes of early resuscitation in 300 patients with either severe sepsis and evidence of hypoperfusion (decreased blood flow to the body tissues) or septic shock who were admitted to a hospital emergency department and randomly assigned to receive one of the two treatments.

The Carolinas Medical Center team found that 34 patients (23 percent) in the ScvO2 group died while in hospital, compared with 25 (17 percent) of patients in the lactate clearance group. There were no differences in treatment-related adverse events.

"These data support the substitution of lactate measurements in peripheral venous blood as a safe and efficacious alternative to a computerized spectrophotometric catheter in the resuscitation of sepsis," the researchers concluded.

The study appears in the Feb. 24 issue of the Journal of the American Medical Association.

Each year in the United States, at least 750,000 people are hospitalized with severe sepsis, and about 500,000 of them are initially treated in emergency departments.

More information

The U.S. National Institute of General Medical Sciences has more about sepsis.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, Feb. 23, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Scientists Probe Sepsis Deadly Secrets
2. Blacks More Likely to Die of Severe Sepsis
3. Research May Yield New Weapons Against Sepsis
4. Customized treatments for sepsis lower treatment time and reduce length of ICU stays
5. Ashwell receptor reduces mortality during sepsis
6. Educational Drive Cut Death Rate From Sepsis
7. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
8. Sepsis Therapy in Preemies Fails to Boost Survival
9. Children's National Research Links Platelets to Sepsis-Related Organ Failure
10. Vanderbilt researchers pioneer an advanced sepsis detection and management system
11. Sepsis Treatment Offers Lifesaving Potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... On Tuesday, April 26, 2016 members of the HomeTown ... of Gov. Nathan Deal on SB 258, the “Rural Health Care Relief” Bill. , ... 70% tax credit to individuals and corporations which donate directly to a “rural hospital” ...
(Date:4/29/2016)... Fort Stewart, GA (PRWEB) , ... April 29, 2016 , ... ... on Monday, May 16, 2016, at its new location in the Exchange Furniture Mall ... including a raffle for a 50-inch Samsung Smart TV. Plus attendees will have the ...
(Date:4/29/2016)... NY (PRWEB) , ... April 29, 2016 , ... ... and engineer of patented products, announces the Gyrociser, an exercise invention which aids ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
(Date:4/29/2016)... ... 2016 , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., ... and throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. ... newly patented safety device secured by nasal surgeons onto the floor of the nasal ...
(Date:4/29/2016)... ... 29, 2016 , ... CURE Media Group , the ... cancer, today announced that Lynne Malestic, RN, of Eisenhower Lucy Curci Cancer Center ... for Oncology Nursing , which honors nurses who have dedicated their careers to ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)...  Hologic, Inc. (Nasdaq: HOLX ) ... fiscal second quarter ended March 26, 2016.  GAAP ... 41.2%, and non-GAAP diluted EPS of $0.47 increased ... a reported basis, and 6.3% on a constant ... good quarter, highlighted by 14.6% growth in non-GAAP ...
(Date:4/27/2016)...   , ... le trimestre, soutenu par une croissance de +42% ... de +16% des ventes aux hôpitaux et cliniques  ... (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de Cellvizio®, ... chiffre d,affaires pour le premier trimestre clos au ...
(Date:4/27/2016)... -- Elekta today announced that its leading-edge ... focal point of seven scientific presentations at ESTRO 35, ... & Oncology, taking place April 29 - May 3. ... and a high-field MRI scanner with sophisticated software that ... in real time. The MR-linac is designed to improve ...
Breaking Medicine Technology: